EDURNE NOVELLA-MAESTRE
No ORCID on file
· 30 papers in corpus
· active 2007-2020
Study types
- article 11
- book-chapter 2
- book 1
Condition tags
- endometriosis 13
Top journals
Frequent coauthors
article
2020
Research questionDoes 3-months of gonadotrophin releasing hormone agonist (GnRHa) treatment before IVF improve clinical pregnancy rate in infertile patients with endometriosis?DesignSingle-blind, placebo-controlled clinical trial of 200 inf…
article
2016
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis
article
2012
ObjectiveTo investigate the effect of antiangiogenic treatment on experimental endometriotic lesion nerve fibers.DesignHeterologous mouse model of endometriosis.SettingUniversity Institute IVI, University Hospital La Fe.Animal(s)Ovariectomi…
article
2012
book-chapter
2011
This chapter addresses the controversies surrounding the impact and surgical management of hydrosalpinges and uterine leiomyoma on in vitro fertilization (IVF) cycle outcome. Evidence accumulated over the last 15 years suggests that either …
book
2011
Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…
article
2011
book-chapter
2010
article
2010
Previous studies in an experimental mouse model of endometriosis have shown that the dopamine agonist (DA) cabergoline (Cb2) reduces angiogenesis and endometriotic lesions, hypothetically binding to the dopamine receptor type-2 (DRD2). To d…
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.
2010
The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.